Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

According to Japanese scientists, certain bacteria found in the digestive systems of frogs and lizards can completely ...

Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, ...

Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GSK’227, now known as risvutatug rezetecan ...